Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysis

The Lancet Oncology

Fecha de publicación: 21 de enero de 2021

DOI: https://doi.org/10.1016/S1470-2045(20)30589-1

Autores: Sathira Kasun Perera, MSc , Susannah Jacob, PhD, Prof Richard Sullivan, MD, Prof Michael Barton, MD

Abstract

Background: Estimating a population-level benchmark rate for use of surgery in the management of cancer helps to identify treatment gaps, estimate the survival impact of such gaps, and benchmark the workforce and other resources, including budgets, required to meet service needs. A population-based benchmark for use of surgery in high-income settings to inform policy makers and service provision has not been developed but was recommended by the Lancet Oncology Commission on Global Cancer Surgery. We aimed to develop and validate a cancer surgery benchmarking model.